| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | MRNA | Common Stock | 3.63K | Feb 27, 2024 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MRNA | Stock Option (Right to Buy) | Award | $0 | +23.6K | $0.00 | 23.6K | Feb 27, 2024 | Common Stock | 23.6K | $96.20 | Direct | F1 | |
| transaction | MRNA | Restricted Stock Units | Award | $0 | +12.4K | $0.00 | 12.4K | Feb 27, 2024 | Common Stock | 12.4K | $0.00 | Direct | F2 | |
| transaction | MRNA | Stock Option (Right to Buy) | Award | $0 | +60.2K | $0.00 | 60.2K | Feb 27, 2024 | Common Stock | 60.2K | $96.20 | Direct | F3 | |
| transaction | MRNA | Restricted Stock Units | Award | $0 | +5.3K | $0.00 | 5.3K | Feb 27, 2024 | Common Stock | 5.3K | $0.00 | Direct | F4 |
| Id | Content |
|---|---|
| F1 | 25% of this option will vest and become exercisable on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |
| F2 | 25% of the shares subject to this restricted stock unit award will vest on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |
| F3 | 50% of this option will vest and become exercisable on February 27, 2026 and the remaining 50% will vest and become exercisable on February 27, 2027, subject to the recipient's continued service. |
| F4 | 25% of the shares subject to this restricted stock unit award will vest on May 27, 2024 with the remainder vesting in three (3) equal quarterly installments thereafter. |